Navigation Links
Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation

SAN DIEGO, March 17 /PRNewswire/ -- Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation Sequencing Conference in San Diego, CA their partnership utilizing the RDT 1000 for sequence enrichment and resequencing validation. A global leader for genetic testing and next generation sequencing services, Ambry Genetics is a CLIA certified and CAP accredited Diagnostic and Genomic Services company providing solutions to both clinical and research clients.


"Ambry Genetics has dedicated its investments in technology for the benefit of the scientific and research community," said Ardy Arianpour, Director of Business Development. "We are motivated to provide our Diagnostic, Genomic and Research customers with the best solutions for their projects, and the addition of RainDance's RDT 1000 adds a sequence-enrichment offering while providing an option for customers that are in need of high-throughput targeted sequencing with a high level of coverage, completeness and speed."

Researchers can utilize the RDT 1000 and Ambry Genetics Next Generation Services to either greatly reduce study time, or to improve study quality by running more samples in the same time within the same experimental budget.

"We're pleased to partner with Ambry Genetics to provide our microdroplet PCR-based solution in conjunction with Ambry's genetic testing and next generation sequencing services " said Chris McNary, Chief Commercial Officer of RainDance Technologies. "PCR is the gold standard for sequence enrichment and allows for high-resolution analysis of rare genetic variations, a focus area of Ambry Genetics' customers". Ambry is currently offering RainDance's sequence enrichment solution and may add two new applications, Methyl-Seq and Ultra-Deep Resequencing in the second half of 2010, further enhancing their customers' ability to understand the origins and pathways of complex diseases."

About Ambry Genetics

Ambry Genetics is a CAP-accredited and CLIA-certified commercial clinical laboratory headquartered in Aliso Viejo, California. Since the company's inception in 2000, it has become a leader in providing genetic services focused on clinical diagnostics and genomic services. Ambry has built a solid reputation for unparalleled service, and has been at the forefront of applying new technologies to the clinical molecular diagnostics market and advancements in disease research. To learn more about testing and services available through Ambry, visit

About RainDance Technologies, Inc.

RainDance Technologies' proprietary technology platform delivers exquisite sensitivity and data quality that inspires scientists, researchers, and clinicians to rethink the way they design experiments, approach discovery, or conduct clinical diagnostics. The core RainStorm technology empowers customers to conduct de novo science in an ultra-high throughput, simple, flexible, and low-cost manner. RainDance's commercial products include instruments and high-value consumables and reagents for sequence enrichment for next-generation sequencing, ultra-deep sequencing, and methylation analysis. RainDance sells directly in the U.S. and in Europe, and is building distribution networks in Europe and Asia-Pacific. RainDance Technologies, with headquarters in Lexington, Massachusetts, and a European sales office in the United Kingdom, has approximately 70 employees worldwide. For more information, please visit

RainStorm is a trademark of RainDance Technologies, Inc.

SOURCE Ambry Genetics

Back to top



SOURCE Ambry Genetics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ambry Genetics Announces Launch of Their StemArray(TM) Product and Services for High Resolution Characterization of Human Stem Cells
2. Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects
3. Interleukin Genetics to Raise $5.3 Million in Registered Direct Offering
4. First Awards Made by London Genetics Proof-of-Concept Fund
5. Viral Genetics CEO Issues State of the Company Update
6. Expanded London Genetics Web Site Emphasises Importance of Pharmacogenetics in Drug Development
7. Viral Genetics Files 2009 3rd Quarter Consolidated Financials and Information Statement at
8. Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis
9. deCODE genetics, Inc. Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets
10. London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference
11. Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Tests Impact on Weight Loss
Post Your Comments:
(Date:11/24/2015)... HILL, N.C. , Nov. 24, 2015  In ... research projects in an effort to quickly uncover new ... position. --> --> ... launch a market research project and ensure that all ... company and industry standards. Another major barrier to efficiently ...
(Date:11/24/2015)... Nueva York , 24 de noviembre ... fabricante del Avery Breathing Pacemaker System, se complace ... MD; Ph.D. como consultor clínico. ... --> Foto -   ... doctor Jonzon es un fisiólogo y consultor en ...
(Date:11/24/2015)... Nov. 24, 2015  DILON Diagnostics and GE Healthcare ... agreement for DILON to distribute GE,s Discovery NM750b Molecular ... signing of this distribution agreement will provide Dilon,s experienced ... Imaging system and is considered an initial step in ... solutions for clinicians and their patients. ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by ... Chicago, IL, UV Angel is evaluating the efficacy of its product and its disinfection ... (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic ...
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I saw a passenger ... thought there had to be a convenient and comfortable way to protect them from ... disabled individuals to safely travel during cold or inclement weather. In doing so, it ...
(Date:11/25/2015)... ... , ... Today, Mothers Against Drunk Driving (MADD) learned that the ... the first time since 2011. In 2014, there were 9,967 fatalities involving an alcohol ... National Highway Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes in ...
(Date:11/25/2015)... ... 25, 2015 , ... Castlewood Treatment Center for Eating Disorders, ... as a result of the $20,000 raised at the center’s recent golf ... Club in Eureka, will help individuals who otherwise might not seek treatment for ...
(Date:11/25/2015)... ... November 25, 2015 , ... In honor of Pulmonary Hypertension ... and groups responsible for advancing care for pulmonary hypertension (PH) patients and helping ... public, will receive special recognition throughout 2016 as part of PHA’s 25th anniversary ...
Breaking Medicine News(10 mins):